Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
3.819
-0.091 (-2.33%)
Feb 9, 2026, 9:57 AM EST - Market open
Orchestra BioMed Holdings Employees
Orchestra BioMed Holdings had 70 employees as of December 31, 2024. The number of employees increased by 14 or 25.00% compared to the previous year.
Employees
70
Change (1Y)
14
Growth (1Y)
25.00%
Revenue / Employee
$40,257
Profits / Employee
-$1,072,871
Market Cap
215.64M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 70 | 14 | 25.00% |
| Dec 31, 2023 | 56 | 11 | 24.44% |
| Sep 30, 2022 | 45 | - | - |
| Jun 30, 2022 | 42 | - | - |
| Mar 31, 2022 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 213 |
| Arcturus Therapeutics Holdings | 176 |
| Alector | 156 |
| Heron Therapeutics | 122 |
| Silence Therapeutics | 116 |
| MediWound | 111 |
| Tonix Pharmaceuticals Holding | 81 |
| Achieve Life Sciences | 25 |
OBIO News
- 4 weeks ago - Orchestra BioMed to Receive Up to $21 Million in Proceeds from Acquisition of Vivasure by Haemonetics - GlobeNewsWire
- 2 months ago - Orchestra BioMed Announces AVIM Therapy and Virtue SAB Program Presentations at ICI Meeting - GlobeNewsWire
- 2 months ago - Orchestra BioMed Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 3 months ago - Orchestra BioMed to Participate in Upcoming Institutional Investor Conferences - GlobeNewsWire
- 3 months ago - Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates - GlobeNewsWire
- 3 months ago - Orchestra BioMed to Host Business Update Call on November 12, 2025 - GlobeNewsWire
- 3 months ago - Orchestra BioMed and Terumo Enter into New $30 Million Virtue SAB Strategic Agreements - GlobeNewsWire
- 3 months ago - Orchestra BioMed Announces First Patients Enrolled in Virtue® SAB US Pivotal IDE Coronary Trial - GlobeNewsWire